Literature DB >> 12586411

The wbiA locus is required for the 2-O-acetylation of lipopolysaccharides expressed by Burkholderia pseudomallei and Burkholderia thailandensis.

Paul J Brett1, Mary N Burtnick, Donald E Woods.   

Abstract

Burkholderia pseudomallei and Burkholderia thailandensis express similar O-antigens (O-PS II) in which their 6-deoxy-alpha-L-talopyranosyl (L-6dTalp) residues are variably substituted with O-acetyl groups at the O-2 or O-4 positions. In previous studies we demonstrated that the protective monoclonal antibody, Pp-PS-W, reacted with O-PS II expressed by wild-type B. pseudomallei strains but not by a B. pseudomallei wbiA null mutant. In the present study we demonstrate that WbiA activity is required for the acetylation of the L-6dTalp residues at the O-2 position and that structural modification of O-PS II molecules at this site is critical for recognition by Pp-PS-W.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586411     DOI: 10.1111/j.1574-6968.2003.tb11536.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  16 in total

1.  Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides.

Authors:  Paul J Brett; Mary N Burtnick; Christian Heiss; Parastoo Azadi; David DeShazer; Donald E Woods; Frank C Gherardini
Journal:  Infect Immun       Date:  2010-11-29       Impact factor: 3.441

2.  Detailed structural analysis of the O-polysaccharide expressed by Burkholderia thailandensis E264.

Authors:  Christian Heiss; Mary N Burtnick; Ian Black; Parastoo Azadi; Paul J Brett
Journal:  Carbohydr Res       Date:  2012-10-11       Impact factor: 2.104

3.  Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei.

Authors:  Richard A Moore; Shauna Reckseidler-Zenteno; Heenam Kim; William Nierman; Yan Yu; Apichai Tuanyok; Jonathan Warawa; David DeShazer; Donald E Woods
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

4.  Development of vaccines against burkholderia pseudomallei.

Authors:  Natasha Patel; Laura Conejero; Melanie De Reynal; Anna Easton; Gregory J Bancroft; Richard W Titball
Journal:  Front Microbiol       Date:  2011-09-27       Impact factor: 5.640

5.  Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes.

Authors:  Paul J Brett; Mary N Burtnick; D Scott Snyder; Jeffrey G Shannon; Parastoo Azadi; Frank C Gherardini
Journal:  Mol Microbiol       Date:  2006-12-05       Impact factor: 3.501

6.  Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.

Authors:  Dina A Moustafa; Jennifer M Scarff; Preston P Garcia; Sara K B Cassidy; Antonio DiGiandomenico; David M Waag; Thomas J Inzana; Joanna B Goldberg
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

7.  Delineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophages.

Authors:  Minal Mulye; Michael P Bechill; William Grose; Viviana P Ferreira; Eric R Lafontaine; R Mark Wooten
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

8.  Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils.

Authors:  Michael E Woodman; Randall G Worth; R Mark Wooten
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

9.  Development of novel O-polysaccharide based glycoconjugates for immunization against glanders.

Authors:  Mary N Burtnick; Christian Heiss; A Michele Schuler; Parastoo Azadi; Paul J Brett
Journal:  Front Cell Infect Microbiol       Date:  2012-11-27       Impact factor: 5.293

10.  Detection of Burkholderia pseudomallei O-antigen serotypes in near-neighbor species.

Authors:  Joshua K Stone; Mark Mayo; Stephanie A Grasso; Jennifer L Ginther; Stephanie D Warrington; Christopher J Allender; Adina Doyle; Shalamar Georgia; Mirjam Kaestli; Stacey M Broomall; Mark A Karavis; Joseph M Insalaco; Kyle S Hubbard; Lauren A McNew; Henry S Gibbons; Bart J Currie; Paul Keim; Apichai Tuanyok
Journal:  BMC Microbiol       Date:  2012-11-05       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.